SAN FRANCISCO (GenomeWeb) – Geisinger Health System said this week that it plans to start rolling out clinical exome sequencing to its patients, starting with an initial 1,000-person pilot that will return a limited number of medically actionable results to patients.
The pilot builds off Geisinger's ongoing research project, the MyCode Community Health Initiative, in which individuals who consent to research can get their exomes sequenced and obtain results from 76 medically actionable genes.